Anticoagulant News and Research

RSS
Study shows younger, female and Hispanic stroke survivors are less likely to take antithrombotic medications

Study shows younger, female and Hispanic stroke survivors are less likely to take antithrombotic medications

Overall use of blood-thinning agents not improving despite more options

Overall use of blood-thinning agents not improving despite more options

European Commission and the EMEA approve Angiox in primary PCI for STEMI

European Commission and the EMEA approve Angiox in primary PCI for STEMI

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Eclipsys reaches milestone: 50 millionth order entered into its EHR system

Eclipsys reaches milestone: 50 millionth order entered into its EHR system

ARYx Therapeutics announces operating results for the third quarter of 2009

ARYx Therapeutics announces operating results for the third quarter of 2009

Catalent Pharma Solutions, Endotis Pharma forge alliance to develop oral formulations of small-glycol drugs

Catalent Pharma Solutions, Endotis Pharma forge alliance to develop oral formulations of small-glycol drugs

ThromboGenics issues business update for the third-quarter of 2009

ThromboGenics issues business update for the third-quarter of 2009

ARYx Therapeutics to complete an out-licensing agreement for clinical development and commercialization of budiodarone

ARYx Therapeutics to complete an out-licensing agreement for clinical development and commercialization of budiodarone

Recruitment of Phase II trial of TB-402 completed ahead of schedule

Recruitment of Phase II trial of TB-402 completed ahead of schedule

PolyMedix completes second successful clinical study of PMX-60056

PolyMedix completes second successful clinical study of PMX-60056

CHMP grants positive opinion to extend the use of Angiox to patients undergoing PCI

CHMP grants positive opinion to extend the use of Angiox to patients undergoing PCI

Patients who are severely ill with H1N1 are at risk for developing PE, says study

Patients who are severely ill with H1N1 are at risk for developing PE, says study

Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material

Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Researchers engineer antidotes for blood-thinner aptamers

Researchers engineer antidotes for blood-thinner aptamers

Polymedix commences Phase 1B study of novel anticoagulant reversing agent

Polymedix commences Phase 1B study of novel anticoagulant reversing agent

New anticoagulant therapy has fewer side-effects than warfarin

New anticoagulant therapy has fewer side-effects than warfarin

Heparin-induced skin lesions may indicate platelets deficit

Heparin-induced skin lesions may indicate platelets deficit

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.